Key result
Elevated TpTe/QTc predicts ~421% higher CRT non-response risk in NICM alongside enlarged LVEDV.
Why the study?
Do specific electro-echocardiographic indices predict non-response to cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy?
Cohort (n=227)
No
Do specific electro-echocardiographic indices predict non-response to cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy?
Specific electro-echocardiographic parameters, such as LVEDV > 255 mL and TpTe/QTc > 0.203, can help predict non-response to CRT in patients with non-ischemic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
These indices were associated with CRT non-response; hypothesis-generating and requires prospective validation before influencing practice.
Cardiac resynchronization therapy (CRT) threw lights on heart failure treatment, however, parts of patients showed nonresponse to CRT. Unfortunately, it lacks effective parameters to predict CRT non-response. In present study, we try to seek effective electro-echocardiographic predictors on CRT non-response. This is a retrospective study to review a total of 227 patients of dyssynchronous heart failure underwent CRT implantation. Logistic analysis was performed between CRT responders and CRT non-responders. The primary outcome was the occurrence of improved left ventricular ejection fraction 1 year after CRT implantation. We concluded that LVEDV > 255 mL (OR = 2.236; 95% CI, 1.016-4.923) rather than LVESV > 160 mL (OR = 1.18; 95% CI, 0.544-2.56) and TpTe/QTc > 0.203 (OR = 5.206; 95% CI, 1.89-14.34) significantly predicted CRT non-response. Oppositely, S wave > 5.7 cm/s (OR = 0.242; 95% CI, 0.089-0.657), E/A > 1 (OR = 0.211; 95% CI, 0.079-0.566), E'/A' > 1 (OR = 0.054; 95% CI, 0.017-0.172), CLBBB (OR = 0.141; 95% CI, 0.048-0.409), and QRS duration >160 ms (OR = 0.52; 95% CI, 0.305-0.922) surprisingly predicted low-probability of CRT non-response.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2017) conducted a cohort in Dyssynchronous heart failure with non-ischemic aetiology (n=227). Cardiac resynchronization therapy (CRT) was evaluated on CRT non-response at 1 year (OR 5.206, 95% CI 1.89-14.34, p=0.001). TpTe/QTc > 0.203 (OR 5.206) and LVEDV > 255 mL (OR 2.236) significantly predicted cardiac resynchronization therapy non-response in patients with non-ischemic cardiomyopathy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: